Predictive value of lymphocyte-to-C-reactive protein ratio for left ventricular thrombus in patients with ST-segment elevation myocardial infarction
Open Access
- 24 April 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1465350
Abstract
Background and purpose: Current evidence suggested a correlation between inflammation and Left Ventricular Thrombus (LVT). The lymphocyte to C-reactive protein ratio (LCR) has been established as be a reliable inflammation marker and is associated with the prognosis of patients with ST-segment elevation myocardial infarction (STEMI). However, its relationship with the occurrence of LVT remains unclear. This study aims to evaluate the effectiveness of LCR in predicting LVT in patients with STEMI after undergoing primary percutaneous coronary intervention (pPCI).Methods: A total of 564 STEMI patients who underwent pPCI at the Affiliated Hospital of Xuzhou Medical University from September 2019 to June 2024 were included. Cardiac magnetic resonance imaging (CMR) was used to assess myocardial infarction characteristics and the presence of LVT. The definition of LCR is the lymphocyte to C-reactive protein ratio.Results: Out of 564 patients, 57 were diagnosed with LVT. The median time for CMR testing was 5 (4, 6) days. Univariate regression analysis showed significant differences in left ventricular ejection fraction (LVEF), peak N-terminal pro B-type natriuretic peptide (peak NT-proBNP), peak high-sensitivity troponin T (peak hsTnT), LCR, Late Gadolinium Enhancement% (LGE%), and Microvascular Obstruction% (MVO%) (p < 0.05). Multivariate regression analysis indicated that LCR was an independent predictor for LVT (P = 0.007, OR: 0.001 95% CI: 0.00–0.123). Receiver operating characteristic (ROC) curve analysis showed that LCR has good predictive ability for LVT (Area under the curve: 0.704, p < 0.001). Integration of integral LCR could significantly improve the discrimination and reclassification accuracy for LVT after STEMI (NRI = 0.517, IDI = 0.030; p < 0.001).Conclusion: Lower LCR is independently associated with the risk of LVT in patients with STEMI after pPCI. Integration of LCR can significantly improve the risk model for LVT.Keywords
This publication has 36 references indexed in Scilit:
- The Role of Inflammation in Early Left Ventricular Thrombus Formation Following ST‐Elevation Myocardial Infarction—A Matched Case‐Control StudyClinical Cardiology, 2024
- Association between the Lymphocyte-to-C-Reactive Protein Ratio and Survival Outcomes in Cancer Patients with GLIM-Defined Malnutrition: A Multicenter StudyThe Journal of nutrition, health and aging, 2022
- Association between inflammation and left ventricular thrombus formation following ST-elevation myocardial infarctionInternational Journal of Cardiology, 2022
- Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancerClinical Nutrition, 2020
- Left ventricular thrombi after STEMI in the primary PCI era: A systematic review and meta-analysisInternational Journal of Cardiology, 2016
- Cardiac MRI and Ischemic Heart Disease: Role in Diagnosis and Risk StratificationCurrent Atherosclerosis Reports, 2016
- Clinical predictors and outcomes of patients with left ventricular thrombus following ST-segment elevation myocardial infarctionJournal of Thrombosis and Thrombolysis, 2015
- Comparison of C-Reactive Protein and Fibrinogen Levels in Patients Having Anterior Wall ST-Segment Elevation Myocardial Infarction With Versus Without Left Ventricular Thrombus (From a Primary Percutaneous Coronary Intervention Cohort)The American Journal of Cardiology, 2013
- The role of T-lymphocyte subpopulations in acute myocardial infarctionEuropean Journal of Internal Medicine, 2003
- Prognostic significance of isolated sinus tachycardia during first three days of acute myocardial infarctionThe American Journal of Medicine, 1984